期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

子宫内膜癌的治疗进展 被引量：1

下载PDF
导出
摘要 子宫内膜癌（endometrial cancer,EC）是起源于子宫内膜上皮的恶性肿瘤。在美国发病率高居妇科恶性肿瘤之首,约占女性总癌症的7%,占女性生殖道恶性肿瘤的20%～30%[1]。在治疗上有很多争议,如手术范围、术后辅助治疗方式方法等,近几年这些方面的临床试验和探索很多,
作者 张丽霞 吴海根
机构地区 南昌大学研究生院医学部 江西省妇幼保健院肿瘤科
出处 《实用临床医学（江西）》 CAS 2011年第8期137-139,共3页 Practical Clinical Medicine
关键词 子宫内膜癌 治疗 手术 放疗 化疗 分子靶向治疗 内分泌治疗
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献22

  • 1Eitan R, Saenz C C, Venkatraman E S, et al. Pilot study pro- spectively evaluating the use of the measurement of preopera- tive sonographic endometrial thickness in postmenopausal pa- tients with endometrial cancer[J]. Menopause, 2005,12 ( 1 ) : 27-30. 被引量：1
  • 2王建六,魏丽惠.子宫内膜癌辅助治疗新进展[J].中华妇产科杂志,2004,39(3):197-200. 被引量：10
  • 3Ben Shachar l,Pavelka J, Cohn D E, et al. Surgical staging /or patients presenting with grade 1 endometrial carcinoma [J ]. Obstet Gynecol,2005,105 (3) :487-493. 被引量：1
  • 4赵晓东,张毅.子宫内膜癌的治疗[J].中国肿瘤临床,2007,34(1):56-59. 被引量：6
  • 5Chee J J, Ho T H, Tay E H,et al. Endometrioid adenocarcino- ma of theuterus., surgieopathologieal correlations and role of pelvic lymphadenec2tomy[J]. Ann Acad Med Singapore,2003, 32(5) :670-675. 被引量：1
  • 6Magrina J F,Weaver A L. Laparoscopic treatment of endome- trial cancer:five-year recurrence and survival rates[J]. Eur J Gynaecol Oncol, 2004,25 (4) : 439 441. 被引量：1
  • 7Peng P, Huang H F,Shen K,et al. Comparative an alysis of laparoseopic surgery and laparotomy for early stage endometri- a| caneer[J]. Zhonghua Fu Chan Ke Za Zhi.2004,39(3),165- 168. 被引量：1
  • 8Kalogiannidis I, Lambrechts S,Amant F, et al. Laparoscopy-as- sisted vaginal hysterectomy compared with abdominal hyster- ectomy in clinical stage I endometrial cancer, safety, recur- rence, and long-term outcome[J]. Am J Obstet Gynecol, 2007, 196(3) : 248. el-eS. 被引量：1
  • 9Frigerio L,Gallo A,Ghezzi F,et al. Laparoscopic-assisted vagi- nal hysterectomy versus abdominal hysterectomy in endometri- al cancer[J]. Int J Gynaecol Obstet,2006,93(3) :209-213. 被引量：1
  • 10Morelli M,Noia R, Costantino A,et al. Laparoseopie lymph- adenectomy as treatment of endometrial cancer[J]. Minerva Ginecol, 2007,59(2) : 111-116. 被引量：1

二级参考文献42

  • 1Slomovitz BM,Lu KH,Johnston T,et al.A phase Ⅲ study of oral mammalian target of rapamycin (moTOR) inhibitor,RAD001 (everolimus),in patients with recurrent endometrial carcinoma (EC)[C].2008 ASCO Annual Meeting Proceedings (Clinical Science Symposium). 被引量：1
  • 2Oza AM,Elit L,Provencher J,et al.A phase Ⅲ study of temsirnlimus (CCI-779) in patients with metastatic and/or locally advanced recurrent endometrial cancer previously treated with chemotherapy:NCIC CTG IND 160b[C].2008ASCO Annual Meeting Proceedings(Post Meeting Edition). 被引量：1
  • 3Nagai N,Oshita T,Fujii T,et al.Prospective analysis of DNA ploidy,proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer[J].Oncol Rep,2000,7(3):551-559. 被引量：1
  • 4Brys M,Semezuk A,Reehberger T,et al.Expression of erbB-1 and erbB-2 genes in normal and pathological human endometrium[J].Oncol Rep,2007,18(1):261-265. 被引量：1
  • 5Albitar L,Laidler LL,Abdallah R,et al.Regulation of signaling phosphoproteins by epidermal growth factor and Iressa (ZD1839) in human endometrial cancer cells that model type Ⅰ and Ⅱ tumors[J].Mol Cancer Ther,2005,4(12):1891-1899. 被引量：1
  • 6Leslie KK,Laidler L,Albitar L,et al.Tyrosine kinase inhibitors in endometrial cancer[J].Int J Gynecol Cancer,2005,15(3):409-411. 被引量：1
  • 7Leslie KK,Sill MW,Darcy KM,et al.Efficacy and safety of gefitinib and potential prognostic value of soluble EGFR,EGFR mutations,and tumor markers in a Gynecologic Oneology Group phase Ⅱ trial of persistent or recurrent endometrial cancer[J].J Clin Oncol,2009,27(suppl):15. 被引量：1
  • 8Jasas KV,Fyles A,Elit L,et al.Phase Ⅱ study of erlotinib (OSI 774) in women with recurrent or metastatic endometrial cancer:NCIC CTG IND-148[J].J Clin Oncol,2004,22(suppl):453-453. 被引量：1
  • 9Nimeiri HS,Oza AM,Morgan RJ,et al.Sorafenib (SOR) in patients (pts) with advanced/recurrent uterine carcinoma (UCA) or carcinosarcoma (CS):A phase Ⅱ trial of the University of Chicago,PMH,and California phase Ⅱ consortia[C].2008 ASCO Annual Meeting Proceedings (Post Meeting Edition). 被引量：1
  • 10Slomovitz BM,Ramnndetta LM,Johnston T,et al.A phase I study of imatinib mesylate and paclitaxei in patients with advanced (stage ⅢC/IV) or recurrent uterine papillary serous carcinoma (UPSC)[J].J Clin Oncol,2007,25(suppl):16025. 被引量：1

共引文献19

同被引文献3

引证文献1

二级引证文献2

实用临床医学（江西）
2011年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部